Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Salpeter

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|October 24, 2022
Targeted nanoparticles modify neutrophil function <i>in vivo</i>Sandra Völs, Naomi Kaisar-Iluz, Merav E Shaul, et al.
Frontiers in Medicine|October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapyShay Golan, Vered Bar, Seth J Salpeter, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|October 24, 2022
Targeted nanoparticles modify neutrophil function <i>in vivo</i>Sandra Völs, Naomi Kaisar-Iluz, Merav E Shaul, et al.
Frontiers in Medicine|October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapyShay Golan, Vered Bar, Seth J Salpeter, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Pageof 2